How does the next generation of the revolution is going to look like? (March 2018)
Blockchain Economic Forum 2018 Singapore (February 2018)
Bank of the Future (December 2017)
Here’s how you’ll liquidate your private shares in 2018 using Blockchain (December 2017)
Axis Roadshow New York (June 2016)
Luxembourg Trade and Investments FinTech Roadshow (June 2016)
PrivatEquity.biz is one of RedHerring's Winners - Amsterdam (April 2016)
Models of Innovation Capital Sharing in the Light of New Legislation (April 2016)
Morning Conference By Finansim (February 2016)
The Exit-from an Event to a Process; Conference at the Yigal Arnon & Co. Law Firm (September 2015)
Startau VIP Cocktail Event 2014
The provision of information in this website is not based on your individual circumstances and should not be relied upon as an assessment of suitability for you of a particular token, product, service, or transaction. It does not constitute investment advice, tax advice or legal advice and The Elephant Platform (formerly PrivatEquity.biz Platform) makes no recommendation as to the suitability of any of the tokens, products, services or transactions mentioned herein. The Elephant is not licensed nor authorized by any financial regulator and shall not be considered as, and may not be used in connection with, offering to sell or the solicitation of an offer to buy tokens in any jurisdiction in which such offer or solicitation is unlawful. The PEC tokens to be allocated by The Elephant are security tokens that are not listed by The Elephant in a regulated security exchange or any other exchange. The information included in this website is intended to “Accredited Investors” only, as this term is defined in the jurisdiction in which they reside (or such similar term in such jurisdictions financial regulations). Non-Accredited investors may not partake in any tokens, products, services or transactions mentioned herein or offered by The Elephant (formerly PrivatEquity.biz).
* Please note that the purchase of the shares of any Target Company may be subjected to right of first refusal of other shareholders, in some cases also to approval of the Target Company’s board of directors or other transfer restrictions as may be applicable.